Charles Fracchia is the Founder of BioBright, a Boston-based company that automates the secure data collection and analysis from laboratory and biomanufacturing environments. BioBright was originally funded by DARPA to create DarwinSync: a scalable and end-to-end encrypted data collection and analytics system. In June 2020, BioBright was acquired by Dotmatics, and in March 2021 merged with Insightful Science to create the leading end-to-end cloud portfolio for the bioeconomy. Fracchia received his graduate education between the MIT Media Lab and Harvard Medical School and obtained his bachelor’s degree from Imperial College London. He has received a number of awards including MIT Technology Review’s 35 under 35, IBM Ph.D. fellowships and the Extraordinary Minds fellowship.